Your Current Position: News and Trends > Company News
-
072020-04The project Tofacitinib successfully had passed on-site inspection of CFDI
-
242020-012020-01-14 to17，The project Enalapril Maleate successfully had passed on-site inspection of CFDI.
-
172020-01The project Pitavastatin Calcium successfully had passed on-site inspection of CFDI
-
302019-112019-11-27 to 29，The project Valsartan and Amlodipine Tablets(I) successfully had passed on-site inspection of CFDI
-
302019-11The project Levamlodipine Besylate Tablet successfully had passed on-site inspection of CFDI
-
302019-11The project Dantraline sodium successfully had passed on-site inspection of CFDI
-
302019-09The project Ticagrelor sodium successfully had passed on-site inspection of CFDI
-
302019-09The project Omeprazole sodium successfully had passed on-site inspection of CFDI
-
302019-07Beijing Scinovo Laboratories Ltd successfully passed the proficiency testing of Bevacizumab in 2019 and obtained the certificate.
-
152019-06The project Diltiazem successfully had passed on-site inspection of CFDI
Beijing Scinovo Laboratories Ltd. Address: 3rd Floor, Building 2, Jinweikai Technology Park, No. 8,Haiying Road, Science City, Fengtai District, Beijing,China |
|
Copyright © Beijing Scinovo Laboratories Ltd. All rights reserved Record number: Beijing ICP No. 17066146